A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation
Top Cited Papers
Open Access
- 1 October 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 106 (7), 2375-2381
- https://doi.org/10.1182/blood-2005-03-0979
Abstract
Prostaglandins, a family of lipidic molecules released during inflammation, display immunomodulatory properties in several models. One use includes exposure of monocyte-derived dendritic cells (DCs) to a cocktail of cytokines that contains prostaglandin E2 (PGE2) for purposes of maturation; such cells are currently being used for cancer immunotherapy trials. Our analysis of the transcription profile of DCs matured in the presence of tumor necrosis factor α (TNFα) and PGE2 revealed a strong up-regulation of indoleamine 2-3 dioxygenase (IDO), an enzyme involved in tryptophan catabolism and implicated in both maternal and T-cell tolerance. Using quantitative assays to monitor levels of IDO mRNA, protein expression, and enzyme activity, we report that PGE2 induces mRNA expression of IDO; however, a second signal through TNF receptor (TNF-R) or a Toll-like receptor (TLR) is necessary to activate the enzyme. Interestingly, use of TNFα, lipopolysaccharide, or Staphylococcus aureus Cowan I strain (SAC) alone does not induce IDO. The effect of PGE2 is mediated by activation of adenylate cyclase via the Gs-protein-coupled receptor E prostanoid-2 (EP2). A better understanding of these regulatory mechanisms and the crosstalk between TNF-R/TLR and EP2 signaling pathways will provide insight into the regulation of T-cell activation by DCs and may help to improve existing immunotherapy protocols.Keywords
This publication has 55 references indexed in Scilit:
- Dendritic cells have the option to express IDO-mediated suppression or notBlood, 2005
- Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: a novel role for the cAMP pathwayBlood, 2005
- Prostaglandin E2 induces IL‐23 production in bone marrow‐derived dendritic cellsThe FASEB Journal, 2004
- Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-DioxygenaseScience, 2002
- Tryptophan-derived Catabolites Are Responsible for Inhibition of T and Natural Killer Cell Proliferation Induced by Indoleamine 2,3-DioxygenaseThe Journal of Experimental Medicine, 2002
- Inhibition of Allogeneic T Cell Proliferation by Indoleamine 2,3-Dioxygenase–expressing Dendritic CellsThe Journal of Experimental Medicine, 2002
- The Plasticity of Dendritic Cell Responses to Pathogens and Their ComponentsScience, 2001
- Coley's toxins, tumor necrosis factor and cancer research: A historical perspectivePharmacology & Therapeutics, 1994
- Immunomodulation by eicosanoids and anti-inflammatory drugsCurrent Opinion in Immunology, 1990
- Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell.The Journal of Experimental Medicine, 1977